Renal cell carcinoma - A retrospective study of 368 patients;Nyrekreft - En retrospektiv undersøkelse av 368 pasienter

Tidsskrift for den Norske Laegeforening

Volumn 122, Issue 25, 2002, Pages 2431-2435

  Beisland, Christian ^a   Medby, Per Christian ^a   Beisland, Hans Olav ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SPLENECTOMY; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0037145446     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kreft i Norge 1997. Oslo: Kreftregisteret, 2000.
2. Beisland C, Medby PC, Sander S, Beisland HO. Nephrectomy - indications, complications and postoperative mortality in 646 consecutive cases. Eur Urol 2000; 37: 58-64.
3. Fosså SD, Aass N, Tveter K, Dahl O. Behandling av nyrekreft med fjernmetastaser. Tidsskr Nor Lægeforen 2000; 120: 2274-8.
4. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969; 101: 297-301.
5. Lightfoot N, Conlon M, Kreiger N, Bisset R, Desai M, Warde P et al. Impact of noninvasive imaging on increased detection of renal cell carcinoma. Eur Urol 2000; 37: 521-7.
6. Bos SD, Mellema CT, Mensink HJA. Increase in incidental renal cell carcinoma in the northern part of the Netherlands. Eur Urol 2000; 37: 267-70.
7. Beisland C, Medby PC, Beisland HO. Renal cell carcinoma: Gender difference in incidental detection and in cancer specific survival. Scand J Urol Nephrol 2002; akseptert for publisering.
8. Uzzo RG, Nowick AC. Nephron sparing surgery for renal tumors: Indications, techniques and outcomes. J Urol 2001; 166: 6-18.
9. Chan DY, Caddedu JA, Jarrett FFM, Kavoussi LR. Laparoscopic radical nephrectomy: Cancer control for renal cell carcinoma. J Urol 2001; 166: 2095-100.
10. Gill IS, Meraney AM, Schweizer D, Savage SS, Hobarth MG, Sung GT et al. Laparoscopic radical nephrectomy in 100 patients: A single center experience from the United States. Cancer 2001; 92: 1843-55.
11. Homma Y, Kawabe K, Kitamura T, Nishimura Y, Shinohara M, Kondo Y et al. Increased incidental detection and reduction mortality in renal cancer: Recent retrospective analysis at eight institutions. Int J Urol 1995; 2: 77-80.
12. Guinan P, Sobin LH, Algaba F, Badellino F, Kameyama S, MacLennan G et al. TNM staging of renal cell carcinoma. Cancer 1997; 80: 992-3.
13. Minervi A, Lilas L, Morelli C, Traversi S, Battaglia R, Cristofani R et al. Regional lymph node dissection in the treatment of renal cell carcinoma: Is it useful in patients with no suspected adenopathy before or during surgery? BJU Int 2001; 88: 169-72.
14. Blom JH, van Poppel H, Marechal JM, Jacqmin D, Sylvester R, Schroeder FH et al. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC genitourinary group. Eur Urol 1999; 36: 570-5.
15. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. Cancer 1971; 28: 1165-77.
16. Blohme I, Fehrman I, Nordén G. Living donor nephrectomy. Complication rates in 490 consecutive cases. Scand J Urol Nephrol 1992; 26: 149-53.
17. Ruiz R, Novick AC, Braun WE, Montague DK, Stewart BH. Transperitoneal live donor nephrectomy. J Urol 1980; 123: 819-21.
18. Mejean A, Vogtn B, Quazza JE; Chretien Y, Dufour B. Mortality and morbidity after nephrectomy for renal cell carcinoma using a transperitoneal anterior subcostal incision. Eur Urol 1999; 36: 298-302.
19. Ljungberg B, Alamdari FI, Holmberg G, Granfors T, Duchek M. Radical nephrectomy is still preferable in the treatment of localized renal cell carcinoma. Eur Urol 1998; 33: 79-85.
20. Da Silva E, Pereiro-Alvarez M, Pereiro-Alvarez B, Ferreira-Chagas C, Pesqueira-Santiago D, Zungri-Telo E. Esplenectomia iatrogena en cirugia del tumor renal. (Iatrogenic splenectomy in surgery of renal tumors.) Actas- Urol- Esp 1997; 21: 476-9.
21. Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal- cell cancer. N Engl J Med 2001; 345: 1655-9.
22. Tsui K-H, Shvarts O, Smith RB, Figlin R, deKernion JB, Belldegrun A. Renal cell carcinoma: Prognostic significance of incidentally detected tumors. J Urol 2000; 163: 426-30.
23. Javidan J, Stricker HJ, Tamboli P, Amin MB, Peabody JO, Deshpande A et al. Prognostic significance of the 1997 TNM classification of renal cell carcinoma. J Urol 1999; 162: 1277-81.
24. Gofrit ON, Shapiro A, Kovalski N, Landau EH, Shenfeld OZ, Pode D. Renal cell carcinoma: Evaluation of the 1997 TNM system and recommendations for follow-up alter surgery. Eur Urol 2001; 39: 669-74.
25. Polascik TJ, Proud CR, Meng MV, Partin AW, Marshall FF. Partial nephrectomy: Technique, complications and pathological findings. J Urol 1995; 154: 1312-8.
26. Novick AC. Nephron sparing surgery for renal cell carcinoma. Annu Rev Med 2002; 53: 393-407.